Literature DB >> 26392463

TRIM38 Negatively Regulates TLR3/4-Mediated Innate Immune and Inflammatory Responses by Two Sequential and Distinct Mechanisms.

Ming-Ming Hu1, Xue-Qin Xie1, Qing Yang1, Chen-Yang Liao1, Wen Ye1, Heng Lin1, Hong-Bing Shu2.   

Abstract

Tripartite motif (TRIM)38 is an E3 ubiquitin ligase that was reported to regulate signaling in innate immune and inflammatory responses in certain cell lines. In this study, we show that Trim38 deficiency markedly increased TLR3- and TLR4-mediated induction of type I IFNs and proinflammatory cytokines, such as TNF-α, IL-1β, and IL-6, in immune cells and in vivo. Trim38 deficiency also caused the mice to be more susceptible to death triggered by polyinosinic-polycytidylic acid, LPS, and Salmonella typhimurium. Mechanistically, TRIM38 catalyzed K48-linked polyubiquitination of the TLR3/4 adapter protein TIR domain-containing adapter-inducing IFN-β at K228 and promoted its proteasomal degradation in immune cells. Moreover, Trim38 was highly induced by type I IFNs, which then negatively regulated TNF-α/IL-1β signaling in IFN-β-primed immune cells, but not unprimed immune cells, by mediating degradation of Tab2 in a lysosomal-dependent process. These results suggest that Trim38 negatively regulates TLR3/4-mediated innate immune and inflammatory responses by two sequential and distinct mechanisms. This study increases our understanding of how the innate immune response is initiated during the early phase of infection to defend against microbial invasion and is efficiently terminated during the late phase to prevent excessive and harmful inflammatory responses.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26392463     DOI: 10.4049/jimmunol.1500859

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Multifaceted roles of TRIM38 in innate immune and inflammatory responses.

Authors:  Ming-Ming Hu; Hong-Bing Shu
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

Review 2.  TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.

Authors:  Milton Roy; Rajesh Singh
Journal:  Cell Mol Life Sci       Date:  2021-07-20       Impact factor: 9.261

3.  TRIM21 Mitigates Human Lung Microvascular Endothelial Cells' Inflammatory Responses to LPS.

Authors:  Lian Li; Jianxin Wei; Rama K Mallampalli; Yutong Zhao; Jing Zhao
Journal:  Am J Respir Cell Mol Biol       Date:  2019-12       Impact factor: 6.914

4.  ZDHHC11 modulates innate immune response to DNA virus by mediating MITA-IRF3 association.

Authors:  Ying Liu; Qian Zhou; Li Zhong; Heng Lin; Ming-Ming Hu; Yan Zhou; Hong-Bing Shu; Shu Li
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

5.  KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.

Authors:  Travis B Lear; Alison C McKelvey; John W Evankovich; Shristi Rajbhandari; Tiffany A Coon; Sarah R Dunn; James D Londino; Bryan J McVerry; Yingze Zhang; Eleanor Valenzi; Christine L Burton; Rachael Gordon; Sebastien Gingras; Karina C Lockwood; Michael J Jurczak; Robert Lafyatis; Mark J Shlomchik; Yuan Liu; Bill B Chen
Journal:  JCI Insight       Date:  2019-10-03

6.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

7.  Tripartite motif proteins: an emerging antiviral protein family.

Authors:  Girish Patil; Shitao Li
Journal:  Future Virol       Date:  2019-01-21       Impact factor: 1.831

8.  A novel prognostic six-CpG signature in glioblastomas.

Authors:  An-An Yin; Nan Lu; Amandine Etcheverry; Marc Aubry; Jill Barnholtz-Sloan; Lu-Hua Zhang; Jean Mosser; Wei Zhang; Xiang Zhang; Yu-He Liu; Ya-Long He
Journal:  CNS Neurosci Ther       Date:  2018-01-19       Impact factor: 5.243

9.  RNF152 positively regulates TLR/IL-1R signaling by enhancing MyD88 oligomerization.

Authors:  Mei-Guang Xiong; Zhi-Sheng Xu; Yu-Hui Li; Su-Yun Wang; Yan-Yi Wang; Yong Ran
Journal:  EMBO Rep       Date:  2020-01-13       Impact factor: 8.807

10.  Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer.

Authors:  Ruiliang Wang; Zongtai Zheng; Shiyu Mao; Wentao Zhang; Ji Liu; Cheng Li; Shenghua Liu; Xudong Yao
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.